222 related articles for article (PubMed ID: 29341450)
1. Characterization of a novel, papain-inducible murine model of eosinophilic rhinosinusitis.
Tharakan A; Dobzanski A; London NR; Khalil SM; Surya N; Lane AP; Ramanathan M
Int Forum Allergy Rhinol; 2018 Apr; 8(4):513-521. PubMed ID: 29341450
[TBL] [Abstract][Full Text] [Related]
2. Mast Cell Deficiency Limits the Development of Chronic Rhinosinusitis in Mice.
Hua X; Naselsky WC; Jania CM; Chason KD; Huang JJ; Doerschuk CM; Graham SM; Senior BA; Tilley SL
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):290-6. PubMed ID: 26681624
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Nrf2 enhances susceptibility to eosinophilic sinonasal inflammation in a murine model of rhinosinusitis.
London NR; Tharakan A; Mendiola M; Sussan TE; Chen M; Dobzanski A; Lane AP; Sidhaye V; Biswal S; Ramanathan M
Int Forum Allergy Rhinol; 2019 Jan; 9(1):114-119. PubMed ID: 30281933
[TBL] [Abstract][Full Text] [Related]
4. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.
Tojima I; Kouzaki H; Shimizu S; Ogawa T; Arikata M; Kita H; Shimizu T
Clin Immunol; 2016 Sep; 170():1-8. PubMed ID: 27422491
[TBL] [Abstract][Full Text] [Related]
5. Multiple airborne allergen-induced eosinophilic chronic rhinosinusitis murine model.
Park SC; Kim SI; Hwang CS; Cho HJ; Yoon JH; Kim CH
Eur Arch Otorhinolaryngol; 2019 Aug; 276(8):2273-2282. PubMed ID: 31098876
[TBL] [Abstract][Full Text] [Related]
6. Development and immunopathological characteristics of an Alternaria-induced chronic rhinosinusitis mouse model.
Shin SH; Ye MK; Lee DW; Chae MH; Choi SY
PLoS One; 2020; 15(6):e0234731. PubMed ID: 32544181
[TBL] [Abstract][Full Text] [Related]
7. Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis.
Tsuda T; Nishide M; Maeda Y; Hayama Y; Koyama S; Nojima S; Takamatsu H; Okuzaki D; Morita T; Nakatani T; Kato Y; Nakanishi Y; Futami Y; Suga Y; Naito Y; Konaka H; Satoh S; Naito M; Izumi M; Obata S; Nakatani A; Shikina T; Takeda K; Hayama M; Inohara H; Kumanogoh A
J Allergy Clin Immunol; 2020 Mar; 145(3):843-854.e4. PubMed ID: 32035658
[TBL] [Abstract][Full Text] [Related]
8. Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbumin.
Kim HC; Lim JY; Kim S; Kim JH; Jang YJ
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3899-3906. PubMed ID: 28828551
[TBL] [Abstract][Full Text] [Related]
9. Induction of nasal polyps using house dust mite and Staphylococcal enterotoxin B in C57BL/6 mice.
Khalmuratova R; Lee M; Kim DW; Park JW; Shin HW
Allergol Immunopathol (Madr); 2016; 44(1):66-75. PubMed ID: 26242569
[TBL] [Abstract][Full Text] [Related]
10. Development of Aspergillus protease with ovalbumin-induced allergic chronic rhinosinusitis model in the mouse.
Kim JH; Yi JS; Gong CH; Jang YJ
Am J Rhinol Allergy; 2014; 28(6):465-70. PubMed ID: 25514482
[TBL] [Abstract][Full Text] [Related]
11. High chemokine ligand 11 levels in nasal lavage fluid: A potential predictor of and therapeutic target for murine eosinophilic chronic rhinosinusitis.
Ren X; Wang Z
Life Sci; 2021 Apr; 271():119218. PubMed ID: 33592198
[TBL] [Abstract][Full Text] [Related]
12. A murine model of eosinophilic chronic rhinosinusitis using the topical application of a vitamin D3 analog.
Kagoya R; Kondo K; Kishimoto-Urata M; Shimizu Y; Kikuta S; Yamasoba T
Allergy; 2021 May; 76(5):1432-1442. PubMed ID: 33058214
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis.
Jang YJ; Lim JY; Kim S; Lee Y; Kweon MN; Kim JH
Front Immunol; 2018; 9():2330. PubMed ID: 30455684
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model.
Kim DW; Khalmuratova R; Hur DG; Jeon SY; Kim SW; Shin HW; Lee CH; Rhee CS
Am J Rhinol Allergy; 2011; 25(6):e255-61. PubMed ID: 22185735
[TBL] [Abstract][Full Text] [Related]
15. Activation of STAT6 by intranasal allergens correlated with the development of eosinophilic chronic rhinosinusitis in a mouse model.
Wei H; Xu L; Sun P; Xing H; Zhu Z; Liu J
Int J Immunopathol Pharmacol; 2022; 36():3946320221109529. PubMed ID: 35726645
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis.
Iinuma T; Okamoto Y; Yamamoto H; Inamine-Sasaki A; Ohki Y; Sakurai T; Funakoshi U; Yonekura S; Sakurai D; Hirahara K; Nakayama T
Ann Allergy Asthma Immunol; 2015 Apr; 114(4):289-98. PubMed ID: 25704964
[TBL] [Abstract][Full Text] [Related]
17. Which are the best murine models to study Eosinophilic Chronic Rhinosinusitis? A contemporary review.
Leite-Santos F; Tamashiro E; de Andrade Batista Murashima A; Anselmo-Lima WT; Valera FCP
Braz J Otorhinolaryngol; 2023; 89(6):101328. PubMed ID: 37734174
[TBL] [Abstract][Full Text] [Related]
18. Pathological mechanisms and clinical features of eosinophilic chronic rhinosinusitis in the Japanese population.
Takeno S; Hirakawa K; Ishino T
Allergol Int; 2010 Sep; 59(3):247-256. PubMed ID: 20567131
[TBL] [Abstract][Full Text] [Related]
19. Topical Vitamin D May Modulate Human Sinonasal Mucosal Responses to House Dust Mite Antigen.
Ma SW; Ende JA; Alvarado R; Christensen JM; Kalish L; Sacks R; Campbell R; Rimmer J; Harvey R
Am J Rhinol Allergy; 2020 Jul; 34(4):471-481. PubMed ID: 32046501
[TBL] [Abstract][Full Text] [Related]
20. Rat model of platelet-activating factor-induced rhinosinusitis.
Jeon SY; Kim JP; Kim EA; Ahn SK; Kim BG
Ann Otol Rhinol Laryngol; 2005 May; 114(5):393-8. PubMed ID: 15966528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
